Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment

被引：0
|
作者：
P. D. Miller
E. N. Schwartz
P. Chen
D. A. Misurski
J. H. Krege
机构：
[1] University of Colorado Health Sciences Center & Colorado Center for Bone Research,Department of Medicine
[2] Northern California Institute for Bone Health,Lilly Research Laboratories
[3] Eli Lilly and Company,undefined
来源：
Osteoporosis International | 2007年 / 18卷
关键词：
Adverse events; Bone mineral density; Fragility fracture; Osteoporosis; Renal impairment; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 68
页数：9
相关论文
共 50 条
  • [21] Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis
    Leder, Benjamin Z.
    Neer, Robert M.
    Wyland, Jason J.
    Lee, Hang W.
    Burnett-Bowie, Sherri-Ann M.
    Finkelstein, Joel S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (08): : 2915 - 2921
  • [22] Profile of teriparatide in the management of postmenopausal osteoporosis
    Sikon, Andrea
    Batur, Pelin
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2010, 2 : 37 - 44
  • [23] ZOLEDRONATE AFTER TERIPARATIDE IN POSTMENOPAUSAL OSTEOPOROSIS
    Ryan, P.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S286 - S286
  • [24] Renal impairment among postmenopausal women with osteoporosis from a large health plan in Israel
    Yu, Jingbo
    Goldshtein, Inbal
    Shalev, Varda
    Chodick, Gabriel
    Ish-Shalom, Sophia
    Sharon, Ofer
    Modi, Ankita
    ARCHIVES OF OSTEOPOROSIS, 2015, 10 (01) : 1 - 7
  • [25] Zoledronate after teriparatide in postmenopausal osteoporosis
    Ryan, P. J.
    BONE, 2009, 44 (02) : S439 - S440
  • [26] Bisphosphonate (BP) Treatment and Renal Impairment (RI) in Women with Postmenopausal Osteoporosis (PMO) in UK
    Xue, Fei
    Wentworth, Charles
    Petraro, Paul
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 271 - 272
  • [27] RENAL IMPAIRMENT AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FROM A LARGE HEALTH PLAN IN ISRAEL
    Yu, J.
    Goldshtein, I.
    Ish-Shalom, S.
    Sharon, O.
    Modi, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1150 - 1150
  • [28] Renal impairment among postmenopausal women with osteoporosis from a large health plan in Israel
    Jingbo Yu
    Inbal Goldshtein
    Varda Shalev
    Gabriel Chodick
    Sophia Ish-Shalom
    Ofer Sharon
    Ankita Modi
    Archives of Osteoporosis, 2015, 10
  • [29] Efficacy of adding teriparatide versus switching to teriparatide in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate
    Cosman, F.
    Wermers, R. A.
    Recknor, C.
    Mauck, K. F.
    Xie, L.
    Glass, E. V.
    Krege, J. H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S127 - S127
  • [30] Correlation between diastolic impairment and lipid metabolism in mild-to-moderate hypertensive postmenopausal women
    Palmiero, P
    Maiello, M
    Passantino, A
    Antoncecchi, E
    Deveredicis, C
    DeFinis, A
    Ostuni, V
    Romano, E
    Mengoli, P
    Caira, D
    Puglia, ARCA
    AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (07) : 615 - 620
12345